Si Yu Shen

Director/Board Member at SINOTHERAPEUTICS INC.

42 year

Consumer Services

Health Technology

Commercial Services

Profile

Si Yu Shen is currently a Director at Shanghai United Imaging Healthcare Co., Ltd., Shanghai Phoebus Medical Technology Co., Ltd., and Sinotherapeutics,.
Inc. Shen received an undergraduate degree from Shanghai Jiao Tong University in 2004 and a doctorate degree from Fudan University in 2012.

Si Yu Shen active positions

Companies	Position	Start
SINOTHERAPEUTICS INC.	Director/Board Member	2018-08-31
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	Director/Board Member	2021-10-08
Shanghai Phoebus Medical Technology Co., Ltd. Shanghai Phoebus Medical Technology Co., Ltd. Medical DistributorsDistribution Services Shanghai Phoebus Medical Technology Co., Ltd. is a provider of chronic disease management solutions, with a focus on monitoring diabetic retinopathy. The company is based in Shanghai, China. The Chinese company uses data to promote collaboration between medical institutions and offers comprehensive services for screening, monitoring, education, and follow-up to help reduce the risk of complications for diabetes and hypertension patients. The company was founded by Yun Wang.	Director/Board Member	2019-04-30

All active positions of Si Yu Shen

Training of Si Yu Shen

Fudan University	Doctorate Degree
Shanghai Jiao Tong University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Si Yu Shen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SINOTHERAPEUTICS INC.	Health Technology
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	Commercial Services

Private companies	1
Shanghai Phoebus Medical Technology Co., Ltd. Shanghai Phoebus Medical Technology Co., Ltd. Medical DistributorsDistribution Services Shanghai Phoebus Medical Technology Co., Ltd. is a provider of chronic disease management solutions, with a focus on monitoring diabetic retinopathy. The company is based in Shanghai, China. The Chinese company uses data to promote collaboration between medical institutions and offers comprehensive services for screening, monitoring, education, and follow-up to help reduce the risk of complications for diabetes and hypertension patients. The company was founded by Yun Wang.	Distribution Services